| 000 | 01825 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250514020207.0 | ||
| 264 | 0 | _c20020117 | |
| 008 | 200201s 0 0 eng d | ||
| 022 | _a0002-9394 | ||
| 024 | 7 |
_a10.1016/s0002-9394(01)01257-0 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOrengo-Nania, S | |
| 245 | 0 | 0 |
_aEvaluation of travoprost as adjunctive therapy in patients with uncontrolled intraocular pressure while using timolol 0.5%. _h[electronic resource] |
| 260 |
_bAmerican journal of ophthalmology _cDec 2001 |
||
| 300 |
_a860-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 | _aAged, 80 and over |
| 650 | 0 | 4 |
_aAntihypertensive Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChemotherapy, Adjuvant |
| 650 | 0 | 4 |
_aCloprostenol _xadministration & dosage |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Evaluation |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlaucoma, Open-Angle _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aIntraocular Pressure _xdrug effects |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aOcular Hypertension _xdrug therapy |
| 650 | 0 | 4 | _aOphthalmic Solutions |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aSafety |
| 650 | 0 | 4 |
_aTimolol _xadministration & dosage |
| 650 | 0 | 4 | _aTravoprost |
| 700 | 1 | _aLandry, T | |
| 700 | 1 | _aVon Tress, M | |
| 700 | 1 | _aSilver, L H | |
| 700 | 1 | _aWeiner, A | |
| 700 | 1 | _aDavis, A A | |
| 773 | 0 |
_tAmerican journal of ophthalmology _gvol. 132 _gno. 6 _gp. 860-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0002-9394(01)01257-0 _zAvailable from publisher's website |
| 999 |
_c11644482 _d11644482 |
||